ProMIS Neurosciences Inc PMN

biogen stock halted

[retiredcop]

Comment by Raymond James is exactly what these guys dont understand... the drug does not have to be really effective, it just has to show an improvement in patients daily life .. even if it just a small improvement... and the FDA is going to get a that evidence today ...the silver bullet treatment will come after Biogen...  

Shares of Biogen BIIB, -7.51% were halted in premarket trading on Friday in advance of a meeting that will have medical experts discuss whether or not the Food and Drug Administration should approve the company's experimental Alzheimer's disease drug. The advisory committee is expected to make a recommendation to the FDA at the end of the meeting; the regulator is not required to follow the advice of the committee but often does. The investigational therapy, aducanumab, would be the first treatment to treat the cognitive decline associated with the disease. But some analysts are skeptical about the drug's effectiveness. Raymond James analyst Steven Seedhouse told investors this week that "we're not sure how else to put it: FDA could approve a drug that may not work." Biogen's stock is up 10.8% so far this year, while the S&P 500 SPX, -0.33% has gained 8.6%.

[M101]

It's a sad day when there is no honour among thieves, analysts should just shut-up and take the money.

[retiredcop]

There could be another explaination for some of this... with negative reporting on Biogen and also the sudden emergence of negative comments and pressure against our company, could it be possible that you have outside forces working to try and descredit us. In the past six months we have gained alot of value as a company and we could be seen as a threat to other companies who saw us failing

[Amorfix]

In the past six months we have gained alot of value? RC i would like you to explain this? Our stock has gone down from 40 cents to 16 cents, I cannot see where the value has been created other then Goldsteins pocket.

[retiredcop]

 Here is my impression of value... OK think back  6-7 months .. what was our ace in the sleeve .. it was PMN310 and at this point we can only compare ourselves to Biogen, because they were the only ones out there that had anything close to what we are trying . Biogen has bad news .. we are painted with the same brush and we start to take on water.  Without notice Biogen is back in

[M101]

So "gained in value" is just an argument in semantics, or value to who? The fact is Gene and Elliot are now very comfortable with plan B, which is long term, because they didn't become billionairs in 5 years as they had hoped. They're never going to tell us that we're now doing plan B, but I mean just follow the money.

[Mole101]

Biogen at adcom meeting just now, official tells FDA committee that, if approved, their Alzheimer's drug label will ask that amyloid testing should conducted before treatment. Could be by PET scan, cerebral spinal fluid testing or (one day) blood biomarker testing. GUESS WHO THE BIOMARKERS TESTER I ....., That reminds me of : ProMIS Neurosciences, Inc. (TSX:PMN.TO) announced